Dp. Brooks et al., CHARACTERIZATION OF CANINE RENAL ENDOTHELIN RECEPTOR SUBTYPES AND THEIR FUNCTION, The Journal of pharmacology and experimental therapeutics, 268(3), 1994, pp. 1091-1097
Binding and renal functional studies were conducted to characterize en
dothelin (ET) receptors in the dog kidney. Binding studies that were p
erformed in renal cortical membranes by using [I-125]-ET-1 and [I-125]
-ET-3 and the ET(A)- and ET(B)-selective ligands, BQ123 (cyclo [D-Trp-
D-Asp-L-Pro-D-Val-L-Leu]) and sarafotoxin 6c (S6c), respectively, reve
aled that the ratios of ET(A) to ET(B) receptors in cortical, medullar
y and papillary membranes were 22:78, 39:61 and 50:50, respectively. I
n vivo studies in the anesthetized dog demonstrated that an intrarenal
artery infusion of ET-1 (0.3-10 ng kg(-1) min(-1)) resulted in a dose
-dependent decrease in renal blood flow (RBF) and glomerular filtratio
n rate(GFR). At a dose of 10 ng kg(-1) min(-1) of ET-1, RBF and GFR de
creased by 82 +/- 6% and 89 +/- 6%, respectively. An infusion of BQ123
(10 mu g kg(-1) min(-1)) into the renal artery resulted in a signific
ant inhibition of the ET-l-induced renal vasoconstriction. At identica
l doses as ET-I, S6c had little effect on either RBF (-3 +/- 6%) or GF
R (-6 +/- 16%). ET-1 decreased urine Row and had little effect on frac
tional sodium excretion, whereas S6c increased both urine flow and fra
ctional sodium excretion. These data indicate that ET-l-induced renal
vasoconstriction in the dog is mediated by ET(A) receptors; however, E
T(B) receptor stimulation may inhibit sodium reabsorption.